Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia

To the Editor, The most common mechanisms for resistance in patients with chronic myeloid leukemia (CML) receiving imatinib mesylate are BCR-ABL kinase domain (KD) mutations. The mutations are stratifi ed according to i...

Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

Objective: Multiple myeloma (MM) is currently incurable due to refractory disease relapse even under novel anti-myeloma treatment. In silico studies are effective for key decision making during clinicopathological battle...

Lack of Early Inflammation Signs of Acute Compartment Syndrome in an Immunodeficient Patient

Lack of Early Inflammation Signs of Acute Compartment Syndrome in an Immunodeficient Patient

Kazanılmış Trombotik Trombositopenik Purpura Olgusu: 25 Yıllık Takipte Üç Rekürens

Flaming Plasma Cell Leukemia

.